MUC5AC and cancer: Aberrant glycosylation occurs in the majority of human cancers, and changes in mucin-type O-glycosylation are key events that play a role in the induction of invasion and metastases [3–5], and generates novel cancer-specific glyco-antigens which can interact with cells of the immune system [6,7].